You are here

ocriplasmin

With FDA panel nod, ThromboGenics closer to first potential drug

Fierce Biotech

Fri, 07/27/12 - 12:52 pm

vitreomacular adhesion

Thrombogenics CEO Discusses Product Pipeline Ahead of Catalysts, FDA Review

Yahoo/Reuters

Mon, 07/9/12 - 10:37 am